We are live on ! Find out more
AAM

Auxier Asset Management Portfolio holdings

AUM $696M
1-Year Est. Return 18.07%
This Fund
S&P 500
This Quarter Est. Return
+15.48%
1 Year Est. Return
+18.07%
3 Year Est. Return
+58.42%
5 Year Est. Return
+82.9%
10 Year Est. Return
+252.62%
AUM
$453M
AUM Growth
+$52.8M
Cap. Flow
-$2.57M
Cap. Flow %
-0.57%
Top 10 Hldgs %
34.67%
Holding
155
New
5
Increased
18
Reduced
80
Closed
8

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$1.9M
2
ABBV icon
AbbVie
ABBV
+$630K
3
BMY icon
Bristol-Myers Squibb
BMY
+$549K
4
FORR icon
Forrester Research
FORR
+$444K
5
PFE icon
Pfizer
PFE
+$408K

Top Sells

Rank Stock Value
1
RTN
Raytheon Company
RTN
+$1.64M
2
AGN
Allergan plc
AGN
+$1.48M
3
BIIB icon
Biogen
BIIB
+$586K
4
ABT icon
Abbott
ABT
+$502K
5
MSFT icon
Microsoft
MSFT
+$441K

Sector Composition

Rank Sector Weight
1 Healthcare 28.41%
2 Consumer Staples 17.95%
3 Financials 17.53%
4 Technology 10.41%
5 Consumer Discretionary 6.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEF
76
DELISTED
Telefonica
TEF
$1.48M 0.33%
364,907
-15,824
-4% -$61.3K
ADP icon
77
Automatic Data Processing
ADP
$108B
$1.41M 0.31%
9,447
-75
-0.8% -$10.7K
PSX icon
78
Phillips 66
PSX
$82.5B
$1.37M 0.3%
19,007
+50
+0.3% +$3.54K
COP icon
79
ConocoPhillips
COP
$144B
$1.28M 0.28%
30,519
+200
+0.7% +$8.09K
ARCO icon
80
Arcos Dorados Holdings
ARCO
$1.76B
$1.26M 0.28%
309,496
+91,448
+42% +$341K
WAFD icon
81
WaFd
WAFD
$2.79B
$1.25M 0.28%
46,512
AMGN icon
82
Amgen
AMGN
$210B
$1.22M 0.27%
5,158
UNM icon
83
Unum
UNM
$14.5B
$1.2M 0.26%
72,187
-150
-0.2% -$2.37K
T icon
84
AT&T
T
$160B
$1.16M 0.26%
50,961
-659
-1% -$15K
YUM icon
85
Yum! Brands
YUM
$40.3B
$1.14M 0.25%
13,137
SBH icon
86
Sally Beauty Holdings
SBH
$1.58B
$1.08M 0.24%
86,486
-100
-0.1% -$1.09K
SBUX icon
87
Starbucks
SBUX
$120B
$1.02M 0.23%
13,893
GM icon
88
General Motors
GM
$77.5B
$982K 0.22%
38,799
-500
-1% -$12.2K
BMY icon
89
Bristol-Myers Squibb
BMY
$135B
$953K 0.21%
16,206
+9,181
+131% +$549K
MNTX
90
DELISTED
Manitex International, Inc.
MNTX
$944K 0.21%
190,006
-400
-0.2% -$1.7K
DHI icon
91
D.R. Horton
DHI
$42.1B
$943K 0.21%
17,000
-50
-0.3% -$2.42K
CAG icon
92
Conagra Brands
CAG
$7.18B
$936K 0.21%
26,625
HRB icon
93
H&R Block
HRB
$5.84B
$928K 0.2%
65,017
TT icon
94
Trane Technologies
TT
$104B
$921K 0.2%
10,355
-45
-0.4% -$3.91K
GILD icon
95
Gilead Sciences
GILD
$168B
$904K 0.2%
11,750
-50
-0.4% -$3.83K
WFC icon
96
Wells Fargo
WFC
$267B
$889K 0.2%
34,739
+398
+1% +$10.9K
AXP icon
97
American Express
AXP
$234B
$838K 0.18%
8,803
-110
-1% -$10.1K
MOS icon
98
The Mosaic Company
MOS
$7.22B
$831K 0.18%
66,406
-450
-0.7% -$5.39K
LINC icon
99
Lincoln Educational Services
LINC
$1.37B
$797K 0.18%
204,261
FSV icon
100
FirstService
FSV
$6.21B
$747K 0.16%
7,410

Similar funds

Auxier Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, Auxier Asset Management held 155 positions worth $453M, up 13% from $401M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Auxier Asset Management's Q2 2020 filing shows 5 new, 18 increased, 80 reduced and 8 closed positions. Its largest new stake was RTX Corp: 30,516 shares worth $1.88M. The largest sale was Raytheon Company, an estimated $1.64M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 29% a quarter earlier, followed by Consumer Staples and Financials.

  • Auxier Asset Management's largest Q2 2020 buy was RTX Corp: 30,516 shares worth $1.88M.
  • Auxier Asset Management added most to AbbVie in Q2 2020, an estimated $630K increase.
  • Auxier Asset Management's biggest Q2 2020 reduction was Biogen, cutting an estimated $586K.
  • Auxier Asset Management fully exited Raytheon Company in Q2 2020, selling an estimated $1.64M.
  • Auxier Asset Management's ten largest holdings make up 35% of its $453M portfolio in Q2 2020.
  • Auxier Asset Management opened 5 new positions and closed 8 in Q2 2020.
  • Auxier Asset Management's portfolio value rose 13% quarter-over-quarter to $453M.

Based on Auxier Asset Management's 13F filing for Q2 2020, filed 20 Aug 2020.